Regional variations in the stem cell assay market reflect disparate levels of research infrastructure development, regulatory environments, healthcare expenditure patterns, and cultural attitudes toward stem cell research and regenerative medicine. North America maintains a dominant position characterized by substantial research funding from agencies such as the National Institutes of...